ARCHIVES

Duke Retraction May Alter IOM Investigation; Review Panel Membership Announced

This article is from The Cancer Letter archive.

Vol. 36 No. 40 | November 5, 2010

Download PDF Visit The Full Archive

Related Articles

Biotheraputics Inc. Markets ‘Custom Made’ Experimental Therapy

August 9, 1985

Panel To Take Up Issues In Grant/Peer Review System, Consider NCAB Membership Requirements

December 11, 1981

Senate Confirms McClellan For FDA

October 25, 2002

Decline In Breast Cancer May Be Related to Drop In HT

March 25, 2011

Model Projects 54,900 New Lung Cancer Cases In 5 Years with Nationwide LDCT Screening

May 30, 2014

NCI Research Project Grant Funding To Exceed $1 Billion In Fiscal 1997

March 14, 1997